関: drug-induced akathisia

WordNet

late-occurring (especially with reference to symptoms of a disease); "tardive dyskinesia"

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 遅発性ジスキネジア：臨床的特徴および診断 tardive dyskinesia clinical features and diagnosis

English Journal

A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.

Suzuki H, Gen K, Takahashi Y.Author information Department of Psychiatry, Suzuki Clinic, Tokyo, Japan.AbstractOBJECTIVE: This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine, IM haloperidol, and IM levomepromazine in acute agitated patients with schizophrenia.
Human psychopharmacology.Hum Psychopharmacol.2014 Jan;29(1):83-8. doi: 10.1002/hup.2376.
OBJECTIVE: This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine, IM haloperidol, and IM levomepromazine in acute agitated patients with schizophrenia.METHODS: The subjects were 122 inpatients. Their clinical symptoms were assessed using Posi
PMID 24424709

Acute and subacute drug-induced movement disorders.

Burkhard PR.Author information Movement Disorders Unit, Department of Neurology, Geneva University Hospitals, Switzerland. Electronic address: pierre.burkhard@hcuge.ch.AbstractMany pharmacological agents may induce a variety of movement disorders, including dystonia, tremor, parkinsonism, myoclonus and dyskinesia, with an acute, subacute or more chronic time course. Motor symptoms may be isolated or part of a more extensive cerebral or systemic condition, such as the neuroleptic malignant syndrome or the serotonin syndrome. Drug-induced movement disorders share a number of features that should make them easy to identify, including a clear temporal relationship between medication initiation and symptom onset, a dose-effect, and, with the exception of tardive syndromes, complete resolution after discontinuation of the offending agent. Diagnosis relies on a thorough medication history. Medications commonly involved include dopamine receptor blockers, antidepressants and anti-epileptics, among many others. Mechanisms underlying drug-induced movement disorders involve blockade, facilitation or imbalance of dopamine, serotonin, noradrenaline and cholinergic neurotransmission in the basal ganglia. The present review focuses on drug-induced movement disorders that typically develop as an acute (hours to days) or subacute (days to weeks) event, including acute dystonic reactions, akathisia, drug-induced parkinsonism, neuroleptic malignant syndrome, serotonin syndrome, parkinsonism-hyperpyrexia syndrome, drug-induced tremor, drug-induced hyperkinesias and movement disorders associated with the use of recreational drugs.
Parkinsonism & related disorders.Parkinsonism Relat Disord.2014 Jan;20 Suppl 1:S108-12. doi: 10.1016/S1353-8020(13)70027-0.
Many pharmacological agents may induce a variety of movement disorders, including dystonia, tremor, parkinsonism, myoclonus and dyskinesia, with an acute, subacute or more chronic time course. Motor symptoms may be isolated or part of a more extensive cerebral or systemic condition, such as the neur
PMID 24262159

A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia.

Suzuki H, Gen K, Takahashi Y.Author information Department of Psychiatry, Suzuki Clinic, 3-34-16 Hamadayama, Suginami, Tokyo, 168-0065, Japan.AbstractOBJECTIVE: This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine and IM haloperidol in agitated elderly patients with schizophrenia at 2 hours postdose.
Therapeutic advances in psychopharmacology.Ther Adv Psychopharmacol.2013 Dec;3(6):314-21. doi: 10.1177/2045125313496113.
OBJECTIVE: This study was a comparative investigation of the clinical efficacy and safety of intramuscular (IM) olanzapine and IM haloperidol in agitated elderly patients with schizophrenia at 2 hours postdose.METHODS: The subjects were 23 inpatients who had been diagnosed with schizophrenia accordi
PMID 24294484